调节免疫系统作为骨髓质疏松综合征和急性骨髓性白血病的治疗点
Caroline M Putnam1, Lahari Kondeti1, Meredith B A Kesler1
1Department of Pharmaceutical Sciences, Marshall University School of Pharmacy, Huntington, WV, USA.
Biochemistry and cell biology = Biochimie et biologie cellulaire
|August 11, 2023
概括
新型免疫疗法正在出现用于骨髓质恶性瘤,如骨髓质疏松综合征 (MDS) 和急性骨髓质白血病 (AML). 本综述探讨了利用或调节免疫系统治疗这些血液癌症的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 骨髓瘤恶性瘤,包括骨髓质综合征 (MDS) 和急性骨髓瘤白血病 (AML),与免疫系统失调有关.
- 造血干细胞和原生细胞 (HSPC) 的缺陷是MDS和AML病变的核心原因.
- 天生的免疫和炎症途径在这些血液癌症的发展和进展中发挥着关键作用.
研究的目的:
- 为MDS和AML提供当前免疫治疗策略的全面概述.
- 要总结各种方法调节免疫系统治疗髓状瘤的恶性病.
- 突出解决MDS和AML免疫失调问题的重要性.
主要方法:
- 关于神经髓瘤恶性瘤免疫疗法的最新进展的文献综述.
- 对专注于MDS和AML先天性免疫和炎症的研究进行分析.
- 综合有关免疫治疗干预措施的数据,如CAR T细胞疗法,疫苗和免疫检查点抑制剂.
主要成果:
- 在开发用于MDS和AML的新型免疫疗法方面取得了重大进展.
- 准先天免疫和炎症途径在减缓疾病进展方面显示出有前途.
- 目前正在研究和应用各种免疫治疗方法.
结论:
- 调节免疫系统为治疗MDS和AML提供了一个有希望的途径.
- 对基于免疫的治疗方法的持续研究对于改善患者的治疗结果至关重要.
- 解决免疫失调是治疗髓状瘤恶性瘤的关键优先事项.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


